Allopurinol may cut diabetes patients' risk of cardiac death

09/5/2013 | (U.K.) · Scotsman (Edinburgh), The

Type 2 diabetes patients who received the gout medication allopurinol showed reduced thickness of the heart muscle wall compared with those who took a placebo, according to a small study in the Journal of the American College of Cardiology. The findings suggest that while skin reactions are a common side effect, the drug may help reduce cardiac deaths in diabetes patients.

View Full Article in: (U.K.) · Scotsman (Edinburgh), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN